While it’s possible the government’s position on transmission of hepatitis C among boomers may have resulted in less testing, it’s critical today boomers forget any fears of stigma and get the easy blood test.
|
|
|||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||
|
U.S.
FDA Approves
Gilead’s Harvoni®
(Ledipasvir/Sofosbuvir)
the first
combination pill
approved to treat
chronic HCV genotype
1 infection. It is
also the first
approved regimen
that does not
require
administration with
interferon or
ribavirin, two
FDA-approved drugs
also used to treat
HCV infection. Read
more:
HARVONI
Hepatitis C Treatment Options Study examines available and future treatments for hepatitis c.
Andrew J. Muir, MD, MHS,
May 22, 2013
|
|
|
|